Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-134-4 | CAS number: 78-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation
In a human Repeated Insult Patch Test which was conducted with 135 human volunteers according to a usual accepted protocol for this type of study, no increase in skin sensitisation reaction was observed after treatment with 12.7% test substance compared to the concurrent solvent controls. It was concluded that the test substance has no sensitising properties.
Dermal absorption
In a toxicokinetic study, one male subject was dermally exposed to massage oil containing 0.5% linalool and 0.6% linalyl acetate. Linalool and linalyl acetate blood levels were detectable 5 minutes after application and were eliminated almost completely after 90 minutes. It was concluded that linalool is absorbed in the blood after dermal application in humans, but is also readily excreted.
Additional information
Skin sensitisation, human, RL1
The senstiziting potential of 12.7% linalool was tested in this human Repeated Insult Patch Test (RIPT). Saline and the vehicle (1:3 EtOH:DEP) were used as control. The skin of 135 human subjects, 45 male and 90 female, was repeatedly exposed (induction, rest, challenge phase) to three patches containing all three substances. During induction, 9 applications of the substance were done in three weeks. Following a rest period of 2 weeks, a challenge was done by application of the same substance on the other side (previously untreated) of the back. Erythema and also edema were assessed and scored after every application period (induction and challenge). In the challenge phase, reactions were scored at 0, 24, 48 and 72 hours after removal of patch with test substance. 119 subjects completed the study (36 male and 83 female). During induction phase 6 reactions were noted for saline, 4 reactions for linalool, and 2 reactions for the vehicle. All reactions were faint, minimal erythema. Linalool only induces slight erythema in one out of 117 and 119 subjects assessed at second and third reading after challenge. 5 reactions after challenge (faint, minimal erythema to erythema) were seen in the saline group. 2 reactions (faint, minimal erythema) were observed in the vehicle group. No difference in effects was observed between application of the test substance and the control substances. When considering the criteria outlined in Annex I of Regulation (EC) No. 1272/2008, linalool will not have to be classified as a sensitiser up to a concentration of 12.7%.
Dermal absorption, human, RL2
The dermal absorption of lavender oil (in massage oil) containing linalool was studied in one male human subject. Massage oil was massaged onto the skin for ten minutes. In total 7.23 mg linalool was applied, which corresponds with a dose of 0.12 mg/kg bw. Linalyl acetate dose was 8.64 in total, representing 0.144 mg/kg bw. Subsequently, the concentration of linalool and linalyl acetate in the blood was determined at several time points by GC-FID and GC-MS. The experiment was repeated three times in the same subject for statistical evaluation. Toxicokinetic parameters were estimated with an open two-compartment standard pharmacokinetic model. The results indicate that linalool and linalyl acetate can be detected in the blood after absorption through skin within 5 minutes after application. The mean plasma concentration (100 ng/mL linalool, 121 ng/mL linalyl acetate) is reached after 19 minutes. Within 90 minutes linalool has been eliminated almost completely. Calculated AUC of linalool is 4927.25 (ng/mL)min, for linalyl acetate this was 4174.50 (ng/mL)min, indicating that the concentration of linalool is significantly higher than that of linalyl acetate. Under the conditions of this test, it can be concluded that linalool and linalyl acetate are absorbed in the blood after dermal application in humans, but are also readily excreted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.